Hims & Hers Health's Fourth Quarter Report: What Investors Should Know

Hims & Hers Health Reports Strong Q4 Earnings
Hims & Hers Health Inc. (NYSE: HIMS) has released its fourth-quarter results, providing insights into its performance and future outlook. The earnings announcement, made after Monday's trading session, highlights key figures for the quarter.
Key Financial Metrics
In the fourth quarter of 2024, Hims & Hers reported a GAAP earnings per share of 11 cents, aligning with analysts' expectations. The revenue for the quarter reached an impressive $481.14 million, exceeding the consensus estimate of $470.31 million. This revenue reflects a substantial increase from $246.62 million in the same quarter of the previous year.
Subscriber Growth and Gross Margin
The company has seen a significant rise in its subscriber base, now totaling 2.2 million. This represents a notable 45% increase from the same quarter last year. Hims & Hers also reported a gross margin of 77% for Q4 2024, down slightly from 83% in Q4 2023, indicating a slight shift in cost structure while still maintaining a profitable operation.
CEO's Insights on Company Growth
Andrew Dudum, the CEO of Hims & Hers Health, commented on the achievements of the past year. He expressed enthusiasm about building a platform that combines personalization and advanced technology, providing a healthcare experience that differs from traditional models. Dudum emphasized the trust that over 2 million subscribers place in Hims & Hers for their health needs and mentioned a continuous influx of new subscribers.
Future Outlook for Hims & Hers
Looking ahead, Hims & Hers anticipates an exciting first quarter of 2025, projecting revenues between $520 million and $540 million. They expect adjusted EBITDA to fall between $55 million to $65 million, reflecting an adjusted EBITDA margin of about 11% to 12%. For the full year 2025, the company forecasts revenue between $2.3 billion and $2.4 billion, with adjusted EBITDA projected between $270 million and $320 million, which translates to an adjusted EBITDA margin of 12% to 13%.
Market Reaction
Following the earnings announcement, shares of Hims & Hers Health experienced a decline, down 17.66% after hours to $42.25. Market reactions to earnings reports can vary, but investors will be keen to see how the company's growth strategies play out in the coming quarters.
Conclusion
The fourth quarter report for Hims & Hers Health Inc. showcases a strong performance with impressive revenue growth and substantial subscriber increase. The outlook for 2025 appears promising, with expectations of continued growth in both revenue and adjusted EBITDA, positioning the company well in the competitive healthcare market.
Frequently Asked Questions
1. What did Hims & Hers report for Q4 earnings?
Hims & Hers reported earnings of 11 cents per share and revenue of $481.14 million.
2. How many subscribers does Hims & Hers have?
The company has reached 2.2 million subscribers, marking a 45% growth year-over-year.
3. What is the forecast for Hims & Hers' revenue in 2025?
Hims & Hers expects to generate revenue between $2.3 billion and $2.4 billion for the full year 2025.
4. What growth strategy did CEO Andrew Dudum mention?
Dudum highlighted the use of personalization and technology to enhance the healthcare experience for subscribers.
5. How did the market react to the earnings announcement?
After the announcement, Hims & Hers shares fell by 17.66%, trading at $42.25 after hours.
About The Author
Contact Lucas Young privately here. Or send an email with ATTN: Lucas Young as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.